Home / Research / Product codes / MXZ Medical-device intelligence
MXZ: Immunohistochemistry Assay, Antibody, Progesterone Receptor FDA product code MXZ: Immunohistochemistry Assay, Antibody, Progesterone Receptor. View classification details, related manufacturers, 510(k) clearances, and recall records.
Classification details
Product code MXZ
FDA device name Immunohistochemistry Assay, Antibody, Progesterone Receptor
Device class 2
Regulation number 864.1860
Medical specialty Hematology
Review panel PA The source does not provide a definition for this entry. Consult the FDA classification and regulation reference for further detail.
Explore hematology records → A product code groups records by FDA classification. It does not establish identical intended uses, commercial availability, or comparative device safety.
Record activity in this scope 13 clearance records and 3 recall records in the covered releases, across 12 source company names and 1 product codes. Dated history runs from Jul 23, 1999 to Mar 6, 2020.
Monthly counts through October 2026 Month 510(k) decisions Recall initiations October 2025 0 0 November 2025 0 0 December 2025 0 0 January 2026 0 0 February 2026 0 0 March 2026 0 0 April 2026 0 0 May 2026 0 0 June 2026 0 0 July 2026 0 0 August 2026 0 0 September 2026 0 0 October 2026 0 0
Product codes represented All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.
Clearances and recall records 16 matching records Device / record Company in FDA record Source Source date BOND Ready-to-Use Primary Antibody Progesterone Receptor (16), Novocastra Liquid Mouse Monoclonal Antibody Progesterone Receptor Clone 16 (Concen… K193393 · MXZLeica Biosystems Newcastle, Ltd. 510(k) Mar 6, 2020FDA decision date BOND Ready-to-Use (RTU) Primary Antibody Progesterone Receptor (16) , Novocastra Concentrated Liquid Mouse Monoclonal Antibody K183102 · MXZLeica Biosystems Newcastle, Limited 510(k) Dec 7, 2018FDA decision date CONFIRM anti-Progesterone Receptor (PR) (1E2) Rabbit Monoclonal Primary Antibody, Catalog Number 05278392001, model 790-4296
Immunohistochemi… Z-3006-2018 · MXZVentana Medical Systems Inc Recall Sep 14, 2018FDA classification date FLEX Monoclonal Mouse Anti-Human Progesterone Receptor, Clone PgR 1294, Ready-to-Use (Dako Omnis) K170005 · MXZDako Denmark A/S 510(k) Dec 21, 2017FDA decision date BOND Ready-to-Use (RTU) Primary Antibody Progesterone Receptor (16), Novocastra Liquid Mouse Monoclonal Antibody Progesterone Receptor Clone 16 K171753 · MXZLeica Biosystems Newcastle, Limited 510(k) Jul 21, 2017FDA decision date FLEX Monoclonal Rabbitt Anti-Human Estrogen Receptor a, Clone EP1, Ready-to-Use (Link); FLEX Monoclonal Mouse Anti-Human Progesterone Receptor, C… K160922 · MXZDako North America, Inc. 510(k) May 3, 2016FDA decision date MONOCLONAL MOUSE ANTI-HUMAN PROGESTERONE RECEPTOR, CLONE PGR 636, READY-TO-USE (LINK) K130861 · MXZDako North America, Inc. 510(k) Dec 9, 2013FDA decision date CONFIRM ANTI-PROGESTORONE RECEPTOR (1E2) RABBIT MONOCLONAL PRIMARY ANTIBODY K103818 · MXZVentana Medical Sytems, Inc. 510(k) Nov 16, 2011FDA decision date VISION BIOSYSTEMS PROGESTERONE RECEPTOR PGR CLONE 16 K062615 · MXZVision Biosystems, Inc. 510(k) Jan 29, 2007FDA decision date NEOMARKERS RABBIT MONOCLONAL ANTI-HUMAN PROGESTERONE RECEPTOR ANTIBODY (CLONE SP2) K060462 · MXZLab Vision Corp. 510(k) Apr 24, 2006FDA decision date DAKOCYTOMATION ER/PR PHARMDX KIT K042884 · MXZDakocytomation California, Inc. 510(k) Feb 15, 2005FDA decision date Mouse anti-TTF-1 concentrate used in a panel designed to differentiate between different types of cancer when used to test a patient. Z-0014-05 · MXZZymed Laboratories Inc. Recall Oct 9, 2004FDA classification date Mouse anti-TTF-1 2nd Gen Predilute used in a panel designed to differentiate between different types of cancer when used to test a patient. Z-0015-05 · MXZZymed Laboratories Inc. Recall Oct 9, 2004FDA classification date BIOGENEX MONOCLONAL ANTI-PROGESTERONE RECEPTOR K012960 · MXZBiogenex Laboratories 510(k) Mar 8, 2002FDA decision date DAKO MONOCLONAL MOUSE ANTI-HUMAN PROGESTERONE RECEPTOR, CLONE PGR 636, ANTIBODY FOR IMMUNOENZYMATIC STAINING K020023 · MXZDako Corp. 510(k) Feb 28, 2002FDA decision date VENTANA PGR PRIMARY ANTIBODY (CLONE 1A6) K990618 · MXZVentana Medical Systems, Inc. 510(k) Jul 23, 1999FDA decision date
Manufacturers in these records Device classifications FDA dataset: Nov 9, 2026
Last successful check: Nov 21, 2026
Source classifications may change.
510(k) clearances FDA dataset: Nov 9, 2026
Last successful check: Nov 21, 2026
FDA publishes this dataset monthly.
Recall records FDA dataset: Nov 19, 2026
Last successful check: Nov 21, 2026
FDA publishes this dataset weekly.
Keep this research moving. Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.
Start a 14-day free trial ↗